STOKE THERAPEUTICS INC (STOK:NASDAQ)
$29.03 -0.31 (-1.0566%)
Analysed STOKE THERAPEUTICS INC (STOK:NASDAQ) News Sources
Stoke Therapeutics to Present at the Cantor Global Healthcare Conference
02-09-2026
yahoo.com
Stoke Therapeutics shares rise as JPMorgan starts coverage with Overweight rating
21-08-2026
advfn.com
Stoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates
03-08-2026
yahoo.com
Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates
03-08-2026
yahoo.com
Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
05-08-2026
yahoo.com
What Is Stoke Therapeutics (STOK) Signaling With A 2 Million Share Shelf Filing?
07-08-2026
yahoo.com
Stoke Therapeutics (STOK) Q2 2026 Earnings Call Transcript
11-08-2026
fool.com
Stoke Therapeutics’ Dravet Trial Tops Enrollment Target With Zero Dropouts
18-08-2026
marketbeat.com
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
18-08-2026
yahoo.com
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
03-09-2026
yahoo.com
What is the current price of STOKE THERAPEUTICS INC (STOK:NASDAQ)?
The current price of STOKE THERAPEUTICS INC (STOK:NASDAQ) is $29.03.
STOKE THERAPEUTICS INC (STOK:NASDAQ) absolute price change since previous trading day?
The absolute price change of STOKE THERAPEUTICS INC (STOK:NASDAQ) since the previous trading day is $-0.31.
STOKE THERAPEUTICS INC (STOK:NASDAQ) percentage price change since previous trading day?
The percentage price change of STOKE THERAPEUTICS INC (STOK:NASDAQ) since the previous trading day is -1.0566%.
What is the most recent average sentiment score for STOKE THERAPEUTICS INC (STOK:NASDAQ)?
The most recent average sentiment score for STOKE THERAPEUTICS INC (STOK:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for STOKE THERAPEUTICS INC (STOK:NASDAQ)?
The most recent sentiment for STOKE THERAPEUTICS INC (STOK:NASDAQ) is .
SEC-8K** Filing Available For STOKE THERAPEUTICS INC (STOK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.